Managemaent Of Dyslipidemia With Vamana Karma (Therapeutic emesis) a Biopurificatory procedure

A COMPARITIVE CLINICAL STUDY ON THE EFFECT OF VAMANA KARMA WITH DHAMARGAVA AND VATSAKA BEEJA FOLLOWED BY LEKHANEEYA GHANA VATI IN THE MANAGEMENT OF MEDOROGA W.S.R TO DYSLIPIDEMIA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011886

Enrollment

Registered

2018-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients suffering with dyslipidemia and having clinical features of medoroga

Interventions

Intervention1: Vamana karma (Therapeutic emesis) with Dhamargava (Luffa cylindrica): Vamana karma (Therapeutic emesis) with Dhamargava and lekhaneeya Ghana Vati in Follow up for 45 days. Control Inter

Eligibility

Inclusion criteria

Inclusion criteria: 1 Serum lipid levels more than normal ranging from: S.cholesterol (201 mg/dl or more) S.Triglycerides (161 mg/dl or more) Serum LDL (131mg/dl or more) Serum VLDL (41mg/dl or more) 2 Having clinical features of Medoroga 3 Fit for Vamana Karma

Exclusion criteria

Exclusion criteria: 1 Age below 20 years & above 60 years. 2 Associated with serious illness like Carcinoma Cardiac Failure, Malignant Hypertension. 3 Not fit for Vamana Karma.

Design outcomes

Primary

Measure	Time frame
Both groups showed significant improvement and result of intergroup comparision was non significantTimepoint: 9 months	—

Secondary

Measure	Time frame
on an average weight reduction upto 5 kgTimepoint: wt reduction was observed within 2 months of trial duration	—

Countries

India

Contacts

Public ContactSangeeta Sharma

National Institute Of Ayurveda

santoshbhatted@rediffmail.com08764322916

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026